Animal Pharmaceutical Market - Global Professional Analysis and Forecast to 2026

Oct 18, 2019  |  187 PAGES  |  REPORT CODE: CMM216473
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Animal Pharmaceutical market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period.

This report presents the market size and development trends by detailing the Animal Pharmaceutical market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Animal Pharmaceutical market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Animal Pharmaceutical industry and will help you to build a panoramic view of the industrial development.

Animal Pharmaceutical Market, By Type:

  • Infectious Diseases

  • Dermatological Diseases (Skin Diseases)

  • Orthopedic Diseases

  • Behavioral Disorders

  • Pain

  • Dental Diseases

  • Parasitology

  • Others

Animal Pharmaceutical Market, By Application:

  • Dogs

  • Cats

  • Horses

  • Other Companion Animals

Some of the leading players are as follows:

  • Zoetis Inc.

  • Koninklijke DSM N.V.

  • Vetoquinol S.A.

  • Nutreco N.V.

  • Novartis AG

  • Eli Lilly and Company

  • Ceva Sante Animale

  • Cargill, Inc.

  • Elanco

  • Virbac S.A.

  • Sanofi S.A.

  • Boehringer Ingelheim GmbH

  • Bayer AG

  • SeQuent Scientific Ltd.

  • Merck & Co., Inc.

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Animal Pharmaceutical Market: Technology Type Analysis

  • 4.1 Animal Pharmaceutical Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Animal Pharmaceutical Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Infectious Diseases

    • 4.3.2 Dermatological Diseases (Skin Diseases)

    • 4.3.3 Orthopedic Diseases

    • 4.3.4 Behavioral Disorders

    • 4.3.5 Pain

    • 4.3.6 Dental Diseases

    • 4.3.7 Parasitology

    • 4.3.8 Others

5 Animal Pharmaceutical Market: Product Analysis

  • 5.1 Animal Pharmaceutical Product Market Share Analysis, 2018 & 2026

  • 5.2 Animal Pharmaceutical Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Animal Pharmaceutical Market: Application Analysis

  • 6.1 Animal Pharmaceutical Application Market Share Analysis, 2018 & 2026

  • 6.2 Animal Pharmaceutical Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Dogs

    • 6.3.2 Cats

    • 6.3.3 Horses

    • 6.3.4 Other Companion Animals

7 Animal Pharmaceutical Market: Regional Analysis

  • 7.1 Animal Pharmaceutical Regional Market Share Analysis, 2018 & 2026

  • 7.2 Animal Pharmaceutical Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Zoetis Inc.

    • 9.1.1 Zoetis Inc. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Koninklijke DSM N.V.

    • 9.2.1 Koninklijke DSM N.V. Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Vetoquinol S.A.

    • 9.3.1 Vetoquinol S.A. Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Nutreco N.V.

    • 9.4.1 Nutreco N.V. Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Novartis AG

    • 9.5.1 Novartis AG Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Eli Lilly and Company

    • 9.6.1 Eli Lilly and Company Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Ceva Sante Animale

    • 9.7.1 Ceva Sante Animale Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Cargill, Inc.

    • 9.8.1 Cargill, Inc. Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Elanco

    • 9.9.1 Elanco Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Virbac S.A.

    • 9.10.1 Virbac S.A. Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Sanofi S.A.

    • 9.11.1 Sanofi S.A. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Boehringer Ingelheim GmbH

    • 9.12.1 Boehringer Ingelheim GmbH Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Bayer AG

    • 9.13.1 Bayer AG Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 SeQuent Scientific Ltd.

    • 9.14.1 SeQuent Scientific Ltd. Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Merck & Co., Inc.

    • 9.15.1 Merck & Co., Inc. Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

 

The List of Tables and Figures (Totals 96 Figures and 125 Tables)

  • Figure Infectious Diseases Animal Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Dermatological Diseases (Skin Diseases) Animal Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Orthopedic Diseases Animal Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Behavioral Disorders Animal Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Pain Animal Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Dental Diseases Animal Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Parasitology Animal Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Others Animal Pharmaceutical market, 2015 - 2026 (USD Million)

  • Figure Dogs market, 2015 - 2026 (USD Million)

  • Figure Cats market, 2015 - 2026 (USD Million)

  • Figure Horses market, 2015 - 2026 (USD Million)

  • Figure Other Companion Animals market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Animal Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table North America Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table North America Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table North America Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Canada Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Canada Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Europe Animal Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table Europe Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Europe Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Europe Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Germany Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Germany Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table France Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table France Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Italy Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Italy Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Spain Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Spain Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Animal Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table China Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table China Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Japan Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Japan Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table India Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table India Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Animal Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table MEA Animal Pharmaceutical market, by country, 2015 - 2026 (USD Million)

  • Table MEA Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table MEA Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table MEA Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Animal Pharmaceutical market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Animal Pharmaceutical market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Animal Pharmaceutical market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Zoetis Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Koninklijke DSM N.V. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Vetoquinol S.A. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Nutreco N.V. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ceva Sante Animale Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cargill, Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Elanco Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Virbac S.A. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi S.A. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boehringer Ingelheim GmbH Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SeQuent Scientific Ltd. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck & Co., Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top